Update on Medical Treatments for Essential Tremor: An International Parkinson and Movement Disorder Society Evidence‐Based Medicine Review
Current evidence from RCTs with at least 1 month of follow-up is insufficient to confidently support the efficacy of available medical treatments for ET. There is a need for longer, higher-quality clinical trials to improve treatment recommendations and guide decision-making for clinicians and patients with ET. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Authors
- Kelly E. Lyons (ORCID: https://orcid.org/0000-0001-7418-1957)
- Monty Silverdale (ORCID: https://orcid.org/0000-0002-3295-6897)
- P. Schwingenschuh
- Verónica Bruno (ORCID: https://orcid.org/0000-0003-2378-6328)
- Joana C. Costa (ORCID: https://orcid.org/0000-0001-7046-2284)
- Claudia M. Testa (ORCID: https://orcid.org/0000-0002-9054-4161)
- Eng-King Tan
- Ai Huey Tan
- Santiago Perez Lloret
- Rob M.A. de Bie
- Bettina Balint
- Deepa Dash
Institutions
- University of North Carolina at Chapel Hill (US)
- Western University (CA)
- Allen Institute for Brain Science (US)
- University of Lisbon (PT)
- University of Calgary (CA)
- Medical University of Graz (AT)
- University of Zurich (CH)
- Universidad de Buenos Aires (AR)
- Manchester Academic Health Science Centre (GB)
- Ottawa Hospital (CA)
- Pontificia Universidad Católica Argentina (AR)
- University of Malaya (MY)
- University Hospital of Zurich (CH)
- University of Kansas Medical Center (US)
- National Neuroscience Institute (SG)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Movement Disorders
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1002/mds.70184
- Citations
- 1
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 39.15
Funders
- Parkinson's Foundation
- Sage Therapeutics
- University of Oxford
- Parkinson Canada
- University of North Carolina at Chapel Hill
- Parkinsonfonden